Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Eli Lilly And Co. (LLY)
Lilly Agewws To Acquire Ajax Therapeutics
4/27/2026 6:50:24 AM
Weekly Buzz: SNY, REGN Get FDA Nod; It's A No For ABBV, GRCE; LLY Acquires Kelonia
4/24/2026 10:34:13 AM
Lilly To Acquire Kelonia Therapeutics To Advance In Vivo CAR-T Cell Therapies
4/20/2026 10:39:37 AM
Lilly Agrees To Acquire Kelonia Therapeutics For Up To $7 Bln
4/20/2026 9:35:49 AM
Lilly To Acquire Kelonia Therapeutics In Deal Worth Up To $7 Bln
4/20/2026 9:03:27 AM
Lilly In Advanced Talks To Acquire Kelonia Therapeutics For More Than $2 Bln : Report
4/19/2026 11:32:13 PM
Weekly Buzz: FDA Okays TVTX, PHG; Rejects REPL; AIP Snaps Up AVNS; PDS, HOTH, SYRE, Paces Trials
4/17/2026 10:38:28 AM
Lilly Plans To Submit Foundayo For Treatment Of Type 2 Diabetes To FDA By Q2-end
4/16/2026 7:13:40 AM
Lilly Reports Positive Topline Results From Phase 3 ACHIEVE-4 Trial In Adults With Type 2 Diabetes And Obesity
4/16/2026 6:47:20 AM
Lilly's Jaypirca Added To Venetoclax And Rituximab Improves PFS In CLL/SLL Study
4/13/2026 8:42:49 AM
Lilly Reports Positive Phase 3 Results For Jaypirca Combination In CLL/SLL
4/13/2026 7:15:56 AM
Lilly Announces Positive Topline Results From Phase 3 BRUIN CLL-322 Trial Of Jaypirca In Patients With CLL/SLL
4/13/2026 6:47:34 AM
GLP-1 Drugs Move Up The Leaderboard As Twin Epidemics Continue To Balloon
4/13/2026 4:30:46 AM
Amazon Pharmacy To Offer Eli Lilly's New GLP-1 Pill Foundayo With Same-Day Delivery
4/9/2026 8:46:00 AM
AC Immune Amends Morphomer Tau Agreement With Lilly
4/7/2026 8:48:19 AM
FDA Approves Eli Lilly's Foundayo Weight-Loss Pill
4/1/2026 6:18:22 PM
Lilly To Acquire Nxera's Partner Centessa Pharma In An Approx.$6.3 Bln Cash And $1.5 Bln CVR Deal
4/1/2026 6:17:08 AM
Lilly To Acquire Centessa; Upfront Consideration Represents Equity Value Of Approx. $6.3 Bln
3/31/2026 7:02:40 AM
Eli Lilly To Acquire Centessa Pharmaceuticals
3/31/2026 6:48:09 AM
Insilico Medicine Strikes $2.75 Bln AI Drug Discovery Deal With Eli Lilly
3/29/2026 11:39:30 AM
«
Previous
1
2
3
4
Next
»